COVID-19 | Page 4 | Pathology & Laboratory Medicine

Pathology & Laboratory Medicine

Elevated soluble urokinase plasminogen activator receptor is associated with renal dysfunction in a Chlorocebus atheiops COVID-19 model.

Gonzalez AA, Olsen EL, Killeen SZ, Blair RV, Seshan SV, Jaimes EA, Roy CJ, Prieto MC. 2023. Elevated soluble urokinase plasminogen activator receptor is associated with renal dysfunction in a Chlorocebus atheiops COVID-19 model.. J Med Primatol. 52(2):131-134.

Read more about Elevated soluble urokinase plasminogen activator receptor is associated with renal dysfunction in a Chlorocebus atheiops COVID-19 model.
Google Scholar

System-wide transcriptome damage and tissue identity loss in COVID-19 patients.

Park J, Foox J, Hether T, Danko DC, Warren S, Kim Y, Reeves J, Butler DJ, Mozsary C, Rosiene J et al.. 2022. System-wide transcriptome damage and tissue identity loss in COVID-19 patients.. Cell Rep Med. 3(2):100522.

Laboratory Interventions to Eliminate Unnecessary Rapid COVID-19 Testing During a Reagent Shortage.

Wulff RT, Qiu Y, Wu C, Calfee DP, Singh HK, Hatch I, Steel PAD, Scofi JE, Westblade LF, Cushing MM. 2022. Laboratory Interventions to Eliminate Unnecessary Rapid COVID-19 Testing During a Reagent Shortage.. Am J Clin Pathol. 158(3):401-408.

Measurements of SARS-CoV-2 antibody dissociation rate constant by chaotrope-free biolayer interferometry in serum of COVID-19 convalescent patients.

Hao Y, Yang HS, Karbaschi M, Racine-Brzostek SE, Li P, Zuk R, Yang YJ, Klasse PJ, Shi Y, Zhao Z. 2022. Measurements of SARS-CoV-2 antibody dissociation rate constant by chaotrope-free biolayer interferometry in serum of COVID-19 convalescent patients.. Biosens Bioelectron. 209:114237.

Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19.

Buyukozkan M, Alvarez-Mulett S, Racanelli AC, Schmidt F, Batra R, Hoffman KL, Sarwath H, Engelke R, Gomez-Escobar L, Simmons W et al.. 2022. Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19.. iScience. 25(7):104612.

Characteristics of natural immunity to SARS-CoV-2 over time in wait-listed dialysis patients and recent kidney transplant recipients.

Lubetzky M, Zhao Z, Sukhu A, Sharma V, Sultan S, Kapur Z, Albakry S, Craig-Schapiro R, Lee JR, Salinas T et al.. 2022. Characteristics of natural immunity to SARS-CoV-2 over time in wait-listed dialysis patients and recent kidney transplant recipients.. Nephrol Dial Transplant. 37(8):1585-1587.

Tolerance for three commonly administered COVID-19 vaccines by healthcare professionals.

Melanson SEF, Zhao Z, Kumanovics A, Love T, Meng QH, Wu AHB, Apple F, Ondracek CR, Schulz KM, Wiencek JR et al.. 2022. Tolerance for three commonly administered COVID-19 vaccines by healthcare professionals.. Front Public Health. 10:975781.

Discovery of a Vertebral Skeletal Stem Cell Driving Spinal Metastases.

Sun J, Hu L, Bok S, Yallowitz AR, Cung M, McCormick J, Zheng LJ, Debnath S, Niu Y, Tan AY et al.. 2023. Discovery of a Vertebral Skeletal Stem Cell Driving Spinal Metastases.. Res Sq.

CALANGO: A phylogeny-aware comparative genomics tool for discovering quantitative genotype-phenotype associations across species.

Hongo JAugusto, de Castro GMarques, Menezes APelri Albu, Picorelli ACésar Rio, da Silva TTayroni Ma, Imada ELuidy, Marchionni L, Del-Bem L-E, Chaves AVieira, Almeida GMagno de F et al.. 2023. CALANGO: A phylogeny-aware comparative genomics tool for discovering quantitative genotype-phenotype associations across species.. Patterns (N Y). 4(6):100728.

Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies.

Elhadad S, Redmond D, Tan A, Huang J, Rodriguez BLorenzo, Racine-Brzostek SE, Subrahmanian S, Ahamed J, Laurence J. 2023. Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies.. Thromb Res. 225:47-56.